 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
|
Articles 
Hannele Yki-Järvinen, Leena Ryysy, Kati Nikkilä, Timo Tulokas, Raimo Vanamo, and Marjatta Heikkilä Combination therapy with bedtime insulin plus metformin prevents weight gain in patients with type 2 diabetes. This regimen also seems superior to other bedtime insulin regimens with respect to improvement in hyperglycemia control and frequency of hypoglycemia.
Kristin L. Nichol, Leslie Baken, and Andrew Nelson For elderly persons with chronic lung disease, influenza is associated with significant adverse health effects and influenza vaccine is associated with substantial health benefits. Among these benefits are fewer outpatient visits, fewer hospitalizations, and fewer deaths.
Venkatarama K. Rao, Elizabeth P. Iademarco, Victoria J. Fraser, and Marin H. Kollef In this study, delays in initiation of tuberculosis treatment were more common than delays in the initial suspicion of tuberculosis. Both types of delays were common even in patients with disease confirmed by a positive smear.
The ICAI Study Group* Short-term treatment with alprostadil-
Brief Communications
Erica Daina, Arrigo Schieppati, and Giuseppe Remuzzi Mycophenate mofetil may be an alternative to steroids and cytotoxic agents in patients with Takayasu arteritis.
Catherine A. Pesek, Ryan Cooley, Krzysztof Narkiewicz, Mark Dyken, Neal L. Weintraub, and Virend K. Somers Theophylline may be a rapid and effective therapy for life-threatening Cheyne–Stokes respiration.
Clinical Reviews
Weerapan Khovidhunkit and Dolores M. Shoback Raloxifene has been shown to have beneficial effects in selected organs in postmenopausal women. Although estrogen remains the drug of choice for hormonal therapy in most postmenopausal women, raloxifene may be an alternative in certain groups of women who have contraindications to estrogen and are at risk for osteoporosis.
Editorials
David M. Nathan The study by Yki-Järvinen and colleagues in this issue adds to the accumulating data supporting the idea that intensive therapy goals can be achieved in patients with type 2 diabetes, with relatively low risk for hypoglycemia or weight gain. This growing body of evidence shows that laissez-faire therapy for type 2 diabetes is no longer acceptable.
Robert M. Schainfeld and Jeffrey M. Isner Prognosis for patients with critical leg ischemia is often poor, and no pharmacotherapy has been effective. In this issue, the ICAI Study Group reports that prostaglandin E1 used to treat this condition had initial benefits that disappeared with time. Another potential medical approach to critical leg ischemia that has shown early promise is the use of gene transfer to repair the vascular system.
Michael A. LaCombe What is responsible for the despair and guilt, reflected in Costigan's essay in this issue, felt by young physicians who witness a patient's death after presumably missing a diagnosis?
On Being a Doctor
David J. Costigan Maybe there are some experiences that you just cannot, and maybe should not, bury.
On Being a Patient
Irvin S. Bauer I wet my bed. That's how it all starts.
Letters Hospitalists: Cost and Quality of Care
Prevalence of Hepatitis C Virus Infection in Patients Hospitalized for Hepatitis A
Transfusion-Transmitted Virus and Mixed Cryoglobulinemia
Effects of Hypertriglyceridemia on Platelet Counts in Automated Hematologic Analysis
Access to Health Care, Socioeconomic Status, and Health
Scott Weingarten This paper describes the rationale for continued attention to preventive care guidelines, the recent effort to organize existing guidelines, currently available compendiums of guidelines, ways to judge the quality of guidelines, and uses of guidelines in daily practice.
Michael Nathan and Robert Scholten
Jock Murray
Valerie P. Weil
Grant Gwinup and Dayna Diven
| ||||||||||||||||||||||||||||||||||||||||||||||
In this Issue
Articles
Previous Issue
-cyclodextrine provides patients with critical leg ischemia a clinically worthwhile benefit that is apparent in the short term but decreases over time.